Pharmaceutical Information |
Drug Name |
Methyl salicylate |
Drug ID |
BADD_D02627 |
Description |
Methyl salicylate (oil of wintergreen or wintergreen oil) is an organic ester naturally produced by many species of plants, particularly wintergreens. The compound was first extracted and isolated from plant species Gaultheria procumbens in 1843. It can be manufactured synthetically and it used as a fragrance, in foods, beverages, and liniments. It forms a colorless to yellow or reddish liquid and exhibits a characteristic odor and taste of wintergreen. For acute joint and muscular pain, methyl salicylate is used as a rubefacient and analgesic in deep heating liniments. It is used as a flavoring agent in chewing gums and mints in small concentrations and added as antiseptic in mouthwash solutions. |
Indications and Usage |
Ointments or liniments containing methyl salicylate are applied topically as counter irritant for relief of acute pain associated with lumbago,sciatica and rheumatic conditions. Local analgesics for human and veterinary medicine. |
Marketing Status |
approved; vet_approved |
ATC Code |
Not Available |
DrugBank ID |
DB09543
|
KEGG ID |
D01087
|
MeSH ID |
C033069
|
PubChem ID |
4133
|
TTD Drug ID |
D0Z0AA
|
NDC Product Code |
72937-001; 71417-004; 55758-108; 82108-114; 43251-2400; 53145-047; 53145-081; 53145-303; 68788-8064; 79643-003; 57598-111; 61734-300; 55758-360; 57598-112; 63255-210; 70211-704; 82944-101; 72917-1000; 53145-082; 70336-718; 50765-4691; 53145-401; 55758-378; 68788-7925; 10357-700; 51551-0310; 61476-100; 81877-620; 14534-227; 10107-420; 50488-1015; 50488-2010; 53145-403; 55758-109; 48251-0220; 52099-8000; 82165-100; 83517-001; 53145-705; 55758-377; 63187-078; 72937-110; 55758-107 |
UNII |
LAV5U5022Y
|
Synonyms |
methyl salicylate | methylsalicylate | Rheumabal | methyl salicylate sodium salt | Metsal Liniment | Hewedolor | Linsal |
|
Chemical Information |
Molecular Formula |
C8H8O3 |
CAS Registry Number |
119-36-8 |
SMILES |
COC(=O)C1=CC=CC=C1O |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|